Previous observations reported a sensitivity of primary AML cells to CSF1R inhibition, in favorable-risk patients, through the secretion of cytokines, in particular HGF, by CSF1R-expressing supportive cells [24]. This evidence concerns the gene CSF1R and acute myeloid leukemia.